Home LiteratureArticle Details
PMID: 18230723 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The PINK1/Parkin pathway regulates mitochondrial morphology.

Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, Pallanck LJ

Abstract

Loss-of-function mutations in the PTEN-induced kinase 1 (PINK1) or parkin genes, which encode a mitochondrially localized serine/threonine kinase and a ubiquitin-protein ligase, respectively, result in recessive familial forms of Parkinsonism. Genetic studies in Drosophila indicate that PINK1 acts upstream of Parkin in a common pathway that influences mitochondrial integrity in a subset of tissues, including flight muscle and dopaminergic neurons. The mechanism by which PINK1 and Parkin influence mitochondrial integrity is currently unknown, although mutations in the PINK1 and parkin genes result in enlarged or swollen mitochondria, suggesting a possible regulatory role for the PINK1/Parkin pathway in mitochondrial morphology. To address this hypothesis, we examined the influence of genetic alterations affecting the machinery that governs mitochondrial morphology on the PINK1 and parkin mutant phenotypes. We report that heterozygous loss-of-function mutations of drp1, which encodes a key mitochondrial fission-promoting component, are largely lethal in a PINK1 or parkin mutant background. Conversely, the flight muscle degeneration and mitochondrial morphological alterations that result from mutations in PINK1 and parkin are strongly suppressed by increased drp1 gene dosage and by heterozygous loss-of-function mutations affecting the mitochondrial fusion-promoting factors OPA1 and Mfn2. Finally, we find that an eye phenotype associated with increased PINK1/Parkin pathway activity is suppressed by perturbations that reduce mitochondrial fission and enhanced by perturbations that reduce mitochondrial fusion. Our studies suggest that the PINK1/Parkin pathway promotes mitochondrial fission and that the loss of mitochondrial and tissue integrity in PINK1 and parkin mutants derives from reduced mitochondrial fission.

MeSH Terms
Animals Cytoskeletal Proteins/genetics,metabolism Drosophila/genetics,metabolism,ultrastructure Drosophila Proteins/genetics,metabolism Eye/anatomy & histology,metabolism GTP-Binding Proteins/genetics,metabolism Gene Dosage Humans Membrane Fusion/genetics Membrane Proteins/metabolism Mitochondria/genetics,ultrastructure Mitochondrial Swelling Mutation Parkinson Disease/enzymology,genetics,pathology Protein Kinases/genetics,metabolism Ubiquitin-Protein Ligases
Chemicals
Cytoskeletal Proteins Drosophila Proteins Marf protein, Drosophila Membrane Proteins OPA1 protein, Drosophila Ubiquitin-Protein Ligases Protein Kinases PTEN-induced putative kinase DRP1 protein, Drosophila GTP-Binding Proteins park protein, Drosophila
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Poole Angela C
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Thomas Ruth E
Andrews Laurie A
McBride Heidi M
Whitworth Alexander J
Pallanck Leo J
References (61)
61 references, click to expand
  1. Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis.
    Hum Mol Genet. 2005 Mar 15;14(6):799-811 PMID: 15689351
  2. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.
    Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10793-8 PMID: 16818890
  3. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease.
    J Cell Biol. 2005 Sep 26;170(7):1067-78 PMID: 16172208
  4. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.
    Hum Mol Genet. 2005 Nov 15;14(22):3477-92 PMID: 16207731
  5. The machines that divide and fuse mitochondria.
    Annu Rev Biochem. 2007;76:751-80 PMID: 17362197
  6. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.
    J Biol Chem. 2000 Nov 17;275(46):35661-4 PMID: 10973942
  7. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology.
    EMBO Rep. 2006 Oct;7(10):1019-22 PMID: 16936636
  8. A lethal defect of mitochondrial and peroxisomal fission.
    N Engl J Med. 2007 Apr 26;356(17):1736-41 PMID: 17460227
  9. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
    Neurobiol Aging. 2006 Apr;27(4):524-9 PMID: 16213628
  10. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion.
    Cell. 2006 Jul 14;126(1):177-89 PMID: 16839885
  11. A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics.
    EMBO J. 2006 Aug 9;25(15):3618-26 PMID: 16874301
  12. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis.
    Dev Cell. 2001 Oct;1(4):515-25 PMID: 11703942
  13. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.
    Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13354-9 PMID: 11078524
  14. Normal mitochondrial dynamics requires rhomboid-7 and affects Drosophila lifespan and neuronal function.
    Curr Biol. 2006 May 23;16(10):982-9 PMID: 16713954
  15. decapentaplegic and wingless are regulated by eyes absent and eyegone and interact to direct the pattern of retinal differentiation in the eye disc.
    Development. 1998 Sep;125(18):3741-51 PMID: 9716539
  16. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2005 May 31;102(22):8024-9 PMID: 15911761
  17. Toxin-induced models of Parkinson's disease.
    NeuroRx. 2005 Jul;2(3):484-94 PMID: 16389312
  18. Parkin's substrates and the pathways leading to neuronal damage.
    Neuromolecular Med. 2003;3(1):1-13 PMID: 12665672
  19. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.
    Neurobiol Dis. 2007 Feb;25(2):401-11 PMID: 17141510
  20. Inhibiting the mitochondrial fission machinery does not prevent Bax/Bak-dependent apoptosis.
    Mol Cell Biol. 2006 Oct;26(20):7397-408 PMID: 17015472
  21. Expanding insights of mitochondrial dysfunction in Parkinson's disease.
    Nat Rev Neurosci. 2006 Mar;7(3):207-19 PMID: 16495942
  22. Parkin and defective ubiquitination in Parkinson's disease.
    J Neural Transm Suppl. 2006;(70):209-13 PMID: 17017531
  23. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice.
    J Biol Chem. 2004 Apr 30;279(18):18614-22 PMID: 14985362
  24. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels.
    Mol Biol Cell. 2007 Aug;18(8):3105-18 PMID: 17553932
  25. Microtubule: a common target for parkin and Parkinson's disease toxins.
    Neuroscientist. 2006 Dec;12(6):469-76 PMID: 17079513
  26. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin.
    Nature. 2006 Jun 29;441(7097):1162-6 PMID: 16672981
  27. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin.
    Nature. 2006 Jun 29;441(7097):1157-61 PMID: 16672980
  28. Mitochondrial dysfunction in Parkinson's disease.
    Cell Death Differ. 2007 Jul;14(7):1261-6 PMID: 17464321
  29. Environment, mitochondria, and Parkinson's disease.
    Neuroscientist. 2002 Jun;8(3):192-7 PMID: 12061498
  30. Wingless signaling induces nautilus expression in the ventral mesoderm of the Drosophila embryo.
    Dev Biol. 1996 May 25;176(1):143-8 PMID: 8654890
  31. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.
    J Neurosci. 2007 Nov 7;27(45):12413-8 PMID: 17989306
  32. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology.
    J Biol Chem. 2007 Jul 27;282(30):21583-7 PMID: 17553808
  33. Mitochondrial fission and fusion mediators, hFis1 and OPA1, modulate cellular senescence.
    J Biol Chem. 2007 Aug 3;282(31):22977-83 PMID: 17545159
  34. Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila.
    Neuron. 2003 Mar 27;37(6):911-24 PMID: 12670421
  35. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress.
    Development. 2004 May;131(9):2183-94 PMID: 15073152
  36. Mutations in dynamin-related protein result in gross changes in mitochondrial morphology and affect synaptic vesicle recycling at the Drosophila neuromuscular junction.
    Genes Brain Behav. 2007 Feb;6(1):42-53 PMID: 17233640
  37. The dynamin-related GTPase Dnm1 regulates mitochondrial fission in yeast.
    Nat Cell Biol. 1999 Sep;1(5):298-304 PMID: 10559943
  38. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease.
    Antioxid Redox Signal. 2007 May;9(5):553-61 PMID: 17465880
  39. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function.
    J Cell Sci. 2007 Apr 1;120(Pt 7):1178-88 PMID: 17341580
  40. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.
    Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4078-83 PMID: 12642658
  41. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans.
    J Biol Chem. 2005 Dec 30;280(52):42655-42668 PMID: 16239214
  42. Mitochondria: more than just a powerhouse.
    Curr Biol. 2006 Jul 25;16(14):R551-60 PMID: 16860735
  43. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1.
    Hum Mol Genet. 2006 Nov 1;15(21):3251-62 PMID: 17000703
  44. Reiterative use of the EGF receptor triggers differentiation of all cell types in the Drosophila eye.
    Cell. 1996 Nov 15;87(4):651-60 PMID: 8929534
  45. Mitochondrial bioenergetics and structural network organization.
    J Cell Sci. 2007 Mar 1;120(Pt 5):838-48 PMID: 17298981
  46. Emerging functions of mammalian mitochondrial fusion and fission.
    Hum Mol Genet. 2005 Oct 15;14 Spec No. 2:R283-9 PMID: 16244327
  47. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death.
    J Cell Biol. 2007 May 7;177(3):439-50 PMID: 17470634
  48. Hereditary early-onset Parkinson's disease caused by mutations in PINK1.
    Science. 2004 May 21;304(5674):1158-60 PMID: 15087508
  49. Parkinsonism genes: culprits and clues.
    J Neurochem. 2006 Nov;99(4):1062-72 PMID: 16836655
  50. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis.
    EMBO J. 2005 Apr 20;24(8):1546-56 PMID: 15791210
  51. Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins.
    Mol Biol Cell. 2002 Dec;13(12):4343-54 PMID: 12475957
  52. Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission.
    Curr Biol. 2004 Feb 17;14(4):340-5 PMID: 14972687
  53. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability.
    Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5703-8 PMID: 15824318
  54. Mitochondrial fusion and fission in mammals.
    Annu Rev Cell Dev Biol. 2006;22:79-99 PMID: 16704336
  55. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission.
    J Biol Chem. 2007 Apr 13;282(15):11521-9 PMID: 17301055
  56. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations.
    Mov Disord. 2004 May;19(5):544-8 PMID: 15133818
  57. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions.
    Neuron. 2005 Aug 4;47(3):365-78 PMID: 16055061
  58. BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential.
    Cancer Lett. 2003 Nov 25;201(2):195-201 PMID: 14607334
  59. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.
    Nat Genet. 2000 Jul;25(3):302-5 PMID: 10888878
  60. Parkin ubiquitinates and promotes the degradation of RanBP2.
    J Biol Chem. 2006 Feb 10;281(6):3595-603 PMID: 16332688
  61. Parkinson's disease: pro-survival effects of PINK1.
    Nature. 2007 Aug 16;448(7155):759-60 PMID: 17700685
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
1091-6490
Published
2008-02-05
Epub
2008-00-29
Pages
1638-43
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC2234197
Subset
IM
Grants
NIA NIH HHS · 5T32AG00057-28A · United States
NICHD NIH HHS · P30-HD02774 · United States
Parkinson's UK · G-4063 · United Kingdom
NINDS NIH HHS · R01 NS041780 · United States
NIA NIH HHS · T32 AG000057 · United States
NINDS NIH HHS · R21 NS053762 · United States
Parkinson's UK · G-0713 · United Kingdom
NINDS NIH HHS · 1R21NS053762-01 · United States
Wellcome Trust · 081987 · United Kingdom
NINDS NIH HHS · 1R01NS41780-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com